Hepatitis C drug Harvoni approved in Europe
European regulators have given the green light to Gilead Sciences' hepatitis C combination treatment Harvoni.
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
19 Nov 14
European regulators have given the green light to Gilead Sciences' hepatitis C combination treatment Harvoni.
10 Oct 13
In recent years, the term ‘patent cliff’ has come to be associated almost exclusively with the pharmaceutical industry.…
22 Feb 13
Pharma, academia and small and medium-sized enterprises have announced a collaboration aimed at facilitating drug discovery. The European…